Medical Supplies and Equipment Business Opportunities

We are a one-stop solution in Hosapete for all medical and hospital needs. - We specialize in a wide range of products, including surgical supplies, lab chemicals, implants, and medical furniture. - With over 12,000 different products, we cater to the requirements of hospitals and pharmacies under one roof. - Our strong client base has grown to 300+ happy customers which includes hospitals and healthcare facilities, who trust us for their medical supplies. - We have a reliable supplier network that ensures our clients receive what they need, when they need it. - We operate entirely offline, with 10 full-time employees and approximately 15 to 20 part-time staff, ensuring continuous operations and steady revenue generation.

Established disposable medical consumables manufacturer specializing in surgical gowns, surgical drapes, and customized drape pack kits for hospitals and healthcare facilities. - Focuses exclusively on single-use disposable products designed to support infection control, hygiene, and patient safety in clinical environments. - Supplies products directly to hospitals, healthcare institutions, and medical facilities through a B2B sales model. - Maintains an active customer base of 15–20 hospitals and healthcare organizations, generating recurring demand for essential medical consumables. - Current production capacity includes approximately 700 surgical gowns per day, operating at around 50% utilization. - Surgical drape manufacturing capacity is approximately 500 units per day, with the ability to increase output to around 800 units daily. - Revenue is generated through the manufacture and sale of disposable surgical products used in operating rooms, clinics, and healthcare settings. - Operates in a growing healthcare segment driven by increasing awareness of infection prevention and the widespread adoption of disposable medical products. - Established approximately six years ago and has built operational expertise in medical consumables manufacturing and hospital supply requirements. - Holds a valid Drug License, supporting regulatory compliance and product credibility within the healthcare sector. - Well-positioned to expand production, increase capacity utilization, and broaden its customer base as demand for disposable healthcare products continues to grow.

• Specialized pet mobility brand focused on improving the lives of specially-abled, paralyzed, and injured animals through customized mobility solutions. • Successfully designed and delivered more than twenty thousand (20k+) mobility carts and wheelchairs for small animals, making it one of the most recognized names in this niche segment. • Revenue is generated through the manufacturing and sale of customized animal mobility carts, rehabilitation solutions, and related support services. Carts are made strictly on an order basis, depending on the requirements. • Established a strong reputation among pet owners, animal rescuers, veterinarians, and animal welfare organizations across India. • The founder has extensive experience in animal mobility and rehabilitation solutions, with a proven track record of innovation and social impact. • Recognized and honored by multiple government departments and institutions for contributions to animal welfare and assistive mobility solutions. • Recipient of prestigious recognitions including the India Book of Records and Star Icon Awards for innovation and social impact. • Strong digital presence and brand recognition, supported by an engaged community of pet lovers and animal welfare advocates. • Formally registered and Certificate of Establishment and a valid business license. • Significant growth potential through strategic partnerships, veterinary networks, e-commerce expansion, and nationwide distribution. • Works in a specialized and socially meaningful segment, addressing a growing need for pet mobility and rehabilitation solutions in a market with relatively few established players.

The business is non-operational due to the owner’s time constraints. - It is equipped with a lab to manufacture contact lens multi-purpose solutions (MPS) and saline rinses, hard lens RGP solutions & lubricant/comfort drops, prescription medical eye drops. For contact lens multi-purpose solutions (MPS): - An incoming operator can utilize the asset to produce at a standard wholesale price point of roughly $2.25 USD per bottle. - At maximum single-shift capacity, the line can generate over $830,000 USD in monthly gross revenue potential. For hard lens RGP solutions & lubricant/comfort drops: - An incoming operator can utilize the asset to produce at a standard wholesale price point of roughly $5.5 USD per bottle. - At maximum single-shift capacity, the line can generate over $1,740,000 USD in monthly gross revenue potential. For prescription medical eye drops: - An incoming operator can utilize the asset to produce at a standard wholesale price point of roughly $14.0 USD per bottle. - At maximum single-shift capacity, the line can generate over $4,300,000 USD in monthly gross revenue potential. - The business is registered as a public limited company with tax registration.

• Global consumer healthcare company focused on smoking harm reduction through patented, drug-free nicotine and tar reduction technology. • Core product is a liquid solution applied to cigarette filters that blocks up to 99% of tar and nicotine while allowing adult smokers to maintain their normal smoking ritual. • Targets adult smokers seeking harm reduction and gradual smoking cessation without prescription drugs or behavioural disruption. • Operates a scalable contract-manufacturing and distribution-led model with sales channels across OTC retail, pharmacies, government health programmes, and international distribution partnerships. • Built around proprietary technology with worldwide patents and trademarks protected until 20 years from now, creating long-term defensibility in the smoking cessation sector. • Regulatory clearances and ingredient approvals secured across major markets, including FDA-approved ingredients in the USA, NHS ethical clearance in the UK, TGA Australia, and approvals across 40+ countries. • Established international footprint with active or contracted distribution and government programmes across GCC countries, Africa, Australia, New Zealand, China, Japan, Singapore, Malaysia, Indonesia, Greece, and Cyprus. • Additional platform extensions planned for cigarette filter capsules, government smoking-reduction tenders, and solutions designed for the global hookah and shisha market. • Positioned to address the growing global smoking cessation and harm-reduction market estimated at over $25 billion, serving approximately 1.1 billion smokers worldwide. • Reports strong financial performance with EBITDA margins of approximately 40%, fully audited financial statements, and no bank borrowings. • Asset-light operating structure enables rapid scalability while maintaining strong profitability and international expansion flexibility. • Management has developed a long-term intellectual property monetisation strategy with an indicative IP valuation target of approximately $50 million in the next 6 years. • Business holds multiple international regulatory clearances, proprietary intellectual property protections, and audited financial compliance across key operating markets.